Synthesis of the alpha and beta anomers of 1-(2-deoxy-D-ribofuranosyl)-4-pyridone.
D000818:Animals; D001665:Binding Sites; D003853:Deoxyribonucleosides / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D003854:Deoxyribonucleotides / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009905:Optical Rotatory Dispersion; D011728:Pyridones / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors
C007263:1-(2-deoxy-D-ribofuranosyl)-4-pyridone; D003853:Deoxyribonucleosides; D003854:Deoxyribonucleotides; D011728:Pyridones; D013940:Thymidylate Synthase